Release Summary

Hanmi Pharmaceutical will present its 11 studies on 4 new drugs including the results of the phase IIb clinical trial of 'efpeglenatide' at the American Diabetes Association 75th Scientific Sessions.

Hanmi Pharmaceutical Co., Ltd.